Toxicology of Melatonin

Journal of Biological Rhythms

Volumn 12, Issue 6, 1997, Pages 697-706

  Guardiola Lemaitre, Béatrice ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

adverse drug reactions; dosage; melatonin; metabolism; pharmacodynamics; pharmacology; side effects; time of administration; toxicology

Indexed keywords

MELATONIN;

ANIMAL; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; MELATONIN;

EID: 0031307984     PISSN: 07487304     EISSN: None     Source Type: Journal    
DOI: 10.1177/074873049701200627     Document Type: Article

References (37)

1. Arendt J., Aldhous M., English J., Marks V., and Arendt JH (1987) Some effects of jet lag and their alleviation by melatonin. Ergonomics 30: 1379-1393.
2. Armstrong SM (1991) Treatment of sleep disorders by melatonin administration. In Advances in Pineal Research, vol 6, A Foldes and R Reiter, eds, pp 263-274, John Libbey, London.
3. Blask DE, Pelletier DB, Hill SM, et al. (1991) Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: Potential involvement of antiestrogenic mechanisms in vivo. J Cancer Res Clin Oncol 117: 526-532.
4. Dahlitz M., Alvarez B., Vignau J., English J., Arendt J., and Parkes JD (1991) Delayed sleep phase syndrome response to melatonin. Lancet 337: 1121-1124.
5. Dollins AB, Lynch HG, Wurtman RJ, Deng MH, Kischka CU, Gleason R., and Lieberman HR (1993) Effects of pharmacological daytime doses of melatonin in human mood and performance. Psychopharmacology 112: 490-496.
6. Dubocovich ML (1988) Pharmacology and function of melatonin receptors. FASEB J 2: 2765-2773.
7. Folkard S., Arendt J., and Clark M. (1993) Can melatonin improve shift workers’ tolerance of the night shift? Some preliminary findings. Chronobiol Int 10: 315-320.
8. Gallo MA (1976) History and scope of toxicology. In Casarett and Doull's Toxicology: The Basic Science of Poisons, CD Klaasen, ed, chap 1, pp 3-11, McGraw-Hill, New York.
9. Heyes MP, Saito K., Devinsky O., and Nadi NS, (1994) Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures. Epilepsia 2: 251-257.
10. Huether G., Hajak G., Reimer A., Poeggeler B., Blômer M., Rodenbeck A., and Rûther E. (1992) The metabolic fate of infused L-tryptophan in men: Possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacology 109: 422-432.
11. Jarett RJ and Keen H. (1970) Further observation on the diurnal variation in oral glucose tolerance. Br Med J 4: 334-337.
12. Karvonen M., Tuomilehto J., and Libman (1993 ) A review of the recent epidemiological data on the worldwide incidence of Type I (insulin-dependent) diabetes mellitus. Diabetologia 36: 883-892.
13. Kawachi I., Colditz GA, Stampfer MJ, Willett WC, Manson JE, Speizer FE, and Hennekens CH (1995) Prospective study of shift work and risk of coronary heart disease in women. Circulation 92: 3178-3182.
14. Kennaway KJ, Hugel HM, Clarke S., Tjandra A., Johnson DW, Royles P., Webb HA, and Carbone F. (1988) Structure activity studies of melatonin analogues in pre-pubertal male rats. Aust J Biol Sci 41: 393-400.
15. Kennaway KJ, Blake P., and Webb HA (1989) A melatonin agonist and N-acetyl-N2-formyl-5-methoxykynurenamine accelerate the reentrainment of the melatonin rhythm following a phase advance of the light-dark cycle. Brain Res 495: 349-354.
16. Klein DC (1974) Circadian rhythms in indole metabolism in the rat pineal gland. In The Neurosciences: Third Study Programme, FO Schmidt, ed, pp 509-515, MIT Press, Cambridge, MA.
17. Lamberg L. (1996) Melatonin potentially useful but safety, efficacy remain uncertain. JAMA 276: 1011-1014.
18. Lewy AJ, Ahmed S., Jackson Jml, and Sack RL (1992) Melatonin shifts circadian rhythms according to a phase-response curve. Chronobiol Int 9: 380-392.
19. Maestroni Gjm and Conti A. (1996) Melatonin and the immune-hematopoietic system: Therapeutic and adverse pharmacological correlates. Neuroimmunomodulation 3: 325-332.
20. Mahle CD, Goggins GD, and Yocca FD (1995) Melatonin modulates vascular tone in rat anterior cerebral artery. Soc Neurosci 21: 183 (Abstract 78.10).
21. Masson-Pévet M., Gauer F., and Pévet P. (1993) Melatonin regulation of melatonin receptor density in the rat pars tuberalis and suprachiasmatic nuclei. In Melatonin and the Pineal Gland from Basic Science to Clinical Application, Y Touitou, J Arendt, and P Pévet, eds, pp 99-104, Elsevier, Amsterdam.
22. Matthews CD, Kennaway DJ, Fellenberg Ajg, Phillipou G., Cox LW, and Seamark RF (1981) Melatonin in man. Adv Biosci 29: 371-381.
23. McArthur AJ, Gillette MU, and Prosser RA (1991) Melatonin directly resets the rat suprachiasmatic circadian clock. Brain Res 565: 158-161.
24. Merrill RA (1996) Regulatory toxicology. In Casarett and Doull's Toxicology: The Basic Science of Poisons, CD Klaasen, ed, chap 34, pp 1011-1024, McGraw-Hill, New York.
25. Moore JG and Goo RH (1987) Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man. Chronobiol Int 4: 111-116.
26. Nagtegaal JE, Smits MG, Van Der Meer YG, and Fischer-Steenvoorden Mgj (1997) Melatonin: A survey of suspected adverse drug reactions. Sleep-Wake Res Netherl 7: 115-118.
27. Nguyen-Legros (1996) Retinal dopamine: Basic mechanisms and clinical implications. In CNS Neurotransmitters and Neuromodulators Dopamine, TW Stone, ed, pp 233-249, CRC, Boca, Raton, Florida.
28. Nguyen-Legros J., Chanut E., Versaux-Botteri C., Simon A., and Trouvin JH (1996) Dopamine inhibits synthesis in photoreceptor cells through a D2-like receptor subtype in the rat retina: Biomedical and histochemical evidence. J Neurochem 67: 2514-2520.
29. Reiter RJ (1980) The pineal and its hormones in the control of reproduction in mammals. Endocrinol Rev J 1: 109-131.
30. Reiter RJ (1997) Antioxidant actions of melatonin. In Advances in Pharmacology, H Sies, ed, vol 38, pp 103-117, Academic Press, Orlando, FL.
31. Reppert SM, Weaver DR, and Ebisawa T. (1994) Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13: 1177-1185.
32. Reppert SM, Godson C., Mahle CD, Weaver DR, Slaugenhaupt SA, and Gusella JF (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor. Proc Natl Acad Sci USA 92: 8734-8738.
33. Sack RL, Lewy AJ, Blood ML, Stevenson J., and Keith LD (1991) Melatonin administration to blind people: Phase advances and entrainment. J Biol Rhythms 6: 249-261.
34. Sarrafzadeh A., Wirz-Justice A., Arendt J., and English J. (1991) Melatonin stabilises sleep onset in a blind man. In Sleep ‘90, JA Home, ed, Patenagel Press, Bochum, Germany.
35. Shima T., Chun S., Niijima A., Bizot-Espiard JG, Guardiola-Lemaitre B., Hosokawa M., and Nagai K. (1997). Melatonin suppresses hyperglycemia caused by intracerebroventricular injection of 2-deoxy-D-glucose in rats. Neurosci Lett 226: 119-122.
36. Waldhauser F. and Dietzel M. (1985) Daily and annual rhythms in human melatonin secretion: Role in puberty control. Ann NY Acad Sci 453: 205-214.
37. Waldhauser F., Waldhauser M., Lieberman HR, Deng MH, Lynch HJ, and Wurtman RJ (1984) Bioavailability of oral melatonin in humans. Neuroendocrinology 39: 307-313.